课题基金 / 基金详情

Function and Regulation of Human Cytochrome P4502S1

Function and Regulation of Human Cytochrome P4502S1
人细胞色素P4502S1的功能和调控
批准号:
7213162
负责人:
OLIVER nmn HANKINSON
金额:
$27.04万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-28 至 2011-07-31

项目摘要

项目成果

OLIVER nmn HANKINSON的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):细胞色素P450是新近发现的一种人细胞色素P450,在上皮组织中广泛表达。我们认为,CYP2S1在环境致癌物的代谢激活以及药物和内源性化合物的代谢中起着重要作用。该提案将解决这一假说,并表征该酶的调节。有三个特定的目的:(1)我们已经在细菌中表达了人的CYP2S1,并证明了它能代谢几种对上皮组织有毒和/或致癌的化合物。我们还将在哺乳动物细胞中过度表达这种酶。使用这些表达系统,我们将筛选额外的底物,以及被CYP2S1激活为诱变(因此可能致癌)衍生物的致癌物。将确定具有代表性的化合物的Km值和Vmax值,并将识别形成的代谢物。(Ii)我们已经证明,在二恶英、致癌的多环芳烃(PAHs)和低氧环境下,都可以诱导细胞色素P450_2S_1。我们将研究潜在的异种生物反应元件(XRE)或潜在的抗氧化剂反应元件(ARE)是否介导了二恶英和/或多环芳烃的诱导,并解决了这样的假设,即由于上述XRE的特定核苷酸序列,在某些细胞中,该基因对多环芳烃的反应比对二恶英的反应更好。我们还将分析低氧诱导该基因的机制,(Iii)我们将产生Cyp2s1基因敲除小鼠,然后产生该小鼠的衍生体,该小鼠包含人类CYP2S1基因,包括其侧翼调节区。我们的研究将用于研究人细胞色素P450_2S_1底物的代谢、代谢的生物学后果以及外源生物和低氧对人细胞色素P_2S_1基因的调节,从而补充和扩展特定的目标1和2。我们的研究可能显示出细胞色素P_2S_1在致癌物、药物和内源性化合物的代谢中的重要作用,并最终可能为减少环境致癌物的有害影响和某些药物在人类群体中的不良影响提供机会。
英文摘要
DESCRIPTION (provided by applicant): CYP2S1 is a recently identified human cytochrome P450, expressed extensively in epithelial tissues. We propose that CYP2S1 plays a significant role in the metabolic activation of environmental procarcinogens, and the metabolism of pharmaceuticals and endogenous compounds. The proposal will address this hypothesis and characterize regulation of the enzyme. There are three specific aims: (i) We have expressed human CYP2S1 in bacteria, and demonstrated that it metabolizes several compounds that are toxic and/or carcinogenic to epithelial tissues. We will also over-express the enzyme in mammalian cells. Using these expression systems, we will screen for additional substrates, and also for procarcinogens that are activated to mutagenic (and therefore probably carcinogenic) derivatives by CYP2S1. The Km and Vmax values will be determined for representative compounds, and the metabolites that are formed will be identified. The degree to which CYP2S1 contributes towards the total metabolism of particular substrates in human epithelial tissues will be determined using an inhibitory antibody to the enzyme, (ii) We have shown that CYP2S1 is inducible by dioxin, carcinogenic polycyclic aromatic hydrocarbons (PAHs), and hypoxia. We will investigate whether the potential Xenobiotic Responsive Elements (XREs), or the potential Antioxidant Response Element (ARE) in the 5' flanking region of the human CYP2S1 gene mediate induction by dioxin and/or PAHs, and address the hypothesis that due to the particular nucleotide sequences of the above XREs, the gene responds better to PAHs than to dioxin in certain cells. We will also analyze the mechanism of hypoxic induction of the gene, (iii) We will generate a knockout mouse for Cyp2s1, and then generate a derivative of this mouse containing the human CYP2S1 gene, including its flanking regulatory regions. This "CYP2S1-humanized" mouse will be used to study the metabolism of substrates of human CYP2S1, the biological consequences of this metabolism, and the regulation of the human CYP2S1 gene by xenobiotics and hypoxia, thus complementing and extending specific aims 1 and 2. Our studies may demonstrate important roles for CYP2S1 in the metabolism of carcinogens, Pharmaceuticals and endogenous compounds, and may ultimately provide opportunities for reducing the deleterious effects of environmental carcinogens and the adverse effects of certain Pharmaceuticals in the human population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A CRISPR-Cas9 screen for novel proteins required for induction of CYP1A1 by AHR
A CRISPR-Cas9 screen for novel proteins required for induction of CYP1A1 by AHR
Function and Regulation of Human Cytochrome P4502S1
Training in Molecular Toxicology
海外基金